Clinical Trial Update: PAN-EU Utilization, Effectiveness and Safety of Ipilimumab Administered in EAP Patients With Advanced Melanoma

View source ↗

Summary

This clinical trial update summarizes the utilization, effectiveness, and safety of ipilimumab in a PAN-European Expanded Access Program for patients with advan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Yervoy (ipilimumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Melanoma | Status: COMPLETED